Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0LT0T
|
||||
| Former ID |
DNC014311
|
||||
| Drug Name |
3-(2-N-Pyrrolyl-acetamino)-rutaecarpine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530639] | ||
| Formula |
C24H23N5O2
|
||||
| Canonical SMILES |
C1CCN(C1)CC(=O)NC2=CC3=C(C=C2)N=C4C5=C(CCN4C3=O)C6=CC=C<br />C=C6N5
|
||||
| InChI |
1S/C24H23N5O2/c30-21(14-28-10-3-4-11-28)25-15-7-8-20-18(13-15)24(31)29-12-9-17-16-5-1-2-6-19(16)26-22(17)23(29)27-20/h1-2,5-8,13,26H,3-4,9-12,14H2,(H,25,30)
|
||||
| InChIKey |
WZTWUTJMQXWCQN-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530639] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530639] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||